Lungershausen said Avance Clinical is focussed on accelerating drug development for its biotech clients, from preclinical stages through to Phase III.... Mar 29
On Wednesday, Moderna, a biotech company based in the United States, announced positive results for a new vaccine that targets both the original Covid strain ... Jun 09
GSK plc today announced positive headline results from five studies of the Phase 3 ASCEND programme, for patients with anaemia due to chronic kidney disease (... Jul 17
First medicine approved in the EU to treat this rare and debilitating genetic condition... Jun 22
... Mar 25
In 2018, the FDA approved LORBRENA for the treatment of patients with ALK-positive metastatic NSCLC whose disease has progressed on crizotinib and at least ... Mar 05
The application includes data for a new, 50 mg tablet that can be dispersed in water and which was developed to facilitate use in children, ... Jan 08
Farxiga could become the first SGLT2 inhibitor approved to treat patients with chronic kidney disease, with and without type-2 diabetes... Jan 06
Pfizer or Moderna 2 doses are needed for effectiveness... Jan 05
Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, ... Dec 29
LORBRENA is a third-generation ALK inhibitor specifically developed to inhibit the most common tumour mutations that drive resistance to current medications and to address ... Dec 29
The OraSure SARS-CoV-2 Antibody ELISA is intended for the qualitative detection of total antibodies to SARS-CoV-2 in human oral fluid specimens ... Dec 22
... Dec 02
As the world races to develop the vaccine for Covid-19, India is looking to be self-reliant in both its development and production.... Dec 01
Mission COVID Suraksha is the targeted effort to enable the development of indigenous, affordable and accessible vaccines for the country and will complement the National ... Nov 30
... Nov 23
Finerenone for patients with chronic kidney disease and type 2 diabetes... Nov 10
These submissions are an important step forward in the commitment to providing an additional treatment option ... Oct 20
Positive pivotal trial data for the investigational use of PD-1 inhibitor Libtayo® (cemiplimab) in first-line locally advanced or metastatic non-small cell lung ... Sep 21
The FDA granted evinacumab breakthrough therapy designation in 2017 for the treatment of hypercholesterolemia in patients with HoFH... Aug 13
AbbVie announced that the Phase 3 ADVANCE trial evaluating the investigational medicine atogepant in migraine prevention... Jul 31
Duvroq is a oral medicine indicated for the treatment of anaemia due to CKD in adult patients not on dialysis and on dialysis... Jul 02
iNova Pharmaceuticals is a multinational pharmaceutical and health care company that sells a wide range of market-leading products... Jun 26
Panacea Biotec and Refana are targeting to manufacture 500 million COVID-19 vaccines over 12 months... Jun 11
Finally Bristol Myers Squib receives approval from EU for Idecabtagene Vicleucel... May 23
-Advertisements-
Monday, May 13, 2024
.jpeg)
